New Zealand. The short-acting calcium channel blocker, nifedipine (Adalat Oros: Bayer, modified release tablets, 30 mg, 60 mg), is no longer contraindicated for use in acute myocardial infarction, including the first 8 days after myocardial infarction.
[See also Pharmaceuticals Newsletter Nos. 5&6, May & June 1997]
Reference: Prescriber Update No. 16, April 1998, Therapeutics Section, Ministry of Health, Wellington.